Gosset Insud Pharma General Information
Insud Pharma operates globally across the entire pharmaceutical value chain. It develops and manufactures active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), branded pharmaceuticals for human and animal care as well as biopharmaceutical products. Its biotech arm mAbxience develops biosimilars and monoclonal antibodies that have reached commercialization in multiple markets. The company has a strong focus on innovation with significant investment in R&D.
Contact Information
Drug Pipeline
No pipeline data available
Key Partnerships
Fresenius Kabi acquired majority stake in mAbxience for global expansion of biosimilars business while maintaining joint operations with Insud Pharma, Collaborations with biotech startups for alternative protein development in Argentina
Insud Pharma Funding
No funding data available